Planta Med 2023; 89(14): 1332
DOI: 10.1055/s-0043-1773980
Abstracts
Monday 3rd July 2023 | Poster Session I
Phytopharmacology I – General; respiratory; cardiac

Pharmacological evaluation of Cosmos sulphureus Cav.

Gabriela Avila-Villarreal
1   Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, México
2   Centro Nayarita de Innovación y Transferencia de Tecnología “Unidad especializada en I+D+i en Calidad de Alimentos y Productos Naturales”, Universidad Autónoma de Nayarit, Tepic, México
,
A. Berenice Aguilar-Guadarrama
3   Centro de Investigaciones Químicas, IICBA, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico
,
Samuel Estrada-Soto
4   Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico
,
Irma-Martha Medina- Díaz
1   Unidad Académica de Ciencias Químico Biológicas y Farmacéuticas, Universidad Autónoma de Nayarit, Tepic, México
› Author Affiliations
 
 

Plants are sources of potential bioactive compounds, in this context plants in the Asteraceae Family have been reported to contain a broad diversity of phenolic compounds, mostly flavonoids, which have a wide range of pharmacological activities. Edible flowers from Cosmos sulphureus Cav. have been used in some world regions due to its potential biological activities such as antioxidant, antidiabetic and anti- inflammatory activities [1]. Current work aimed to determine the phytochemical content of C. sulphureus and evaluate its pharmacological activity by in vitro and ex vivo models.

A hydroalcoholic extract (HE-Cs) from inflorescences was obtained by maceration. n-Hexane (Hxn), ethyl acetate (EtOAc) and butanol (BuOH) fractions were obtained by a liquid-liquid extraction from HE-Cs. Extract and fractions were evaluated in vitro for α-glucosidases inhibition, and vasorelaxant effect in an ex vivo model using isolated rat aortic rings precontracted with noradrenaline with and without endothelium. In vitro α-glucosidases inhibition assay showed significant inhibition for EtOAc (41±0.6%) and BuOH (76.6±1.03%) fractions contrasted with Camelia sinensis (96.3±1.22%), a well characterised plant extract inhibitor of intestinal α-glucosidase enzymes.

As a result of the ex vivo evaluations, the EtOAc-Cs (Emax=91.40%; EC50=130.88 µg/mL) fractions showed the best vasorelaxant effect in a partially endothelium dependent manner ([Fig. 1]). LC-MS chromatogram and mass spectrum analysis from EtOAc-Cs allowed us to tentatively identify apigenin, quercetin and chlorogenic acid. These results partially support the valuable potential attributed to C. sulphureus.

Zoom
Fig. 1 The ex vivo vasorelaxant effect of the EtOAc-Cs extract of C. sulphureus inflorescences


Publication History

Article published online:
16 November 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany


 
Zoom
Fig. 1 The ex vivo vasorelaxant effect of the EtOAc-Cs extract of C. sulphureus inflorescences